Загрузка видео...

Не удалось загрузить видео

На главную

Today we’re sharing a defining moment for Cellular Intelligence, for cell therapy, and hopefully one day for patients with Parkinson’s. We’re acquiring STEM-PD, a Phase 2-ready allogeneic cell therapy program for Parkinson’s from Novo Nordisk, who'll also be investing in CI.

MichaBreakstone's profile picture

Micha Breakstone

1,244 subscribers

18,301 просмотров • 24 дней назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

#BREAKINGNEWS: Bayer & BlueRock announce positive results in Phase I clinical study for a new investigational stem cell therapy for Parkinson’s disease (PD). An important milestone in our quest to meet unmet medical needs of those living with PD:
0:25

#BREAKINGNEWS: Bayer & BlueRock announce positive results in Phase I clinical study for a new investigational stem cell therapy for Parkinson’s disease (PD). An important milestone in our quest to meet unmet medical needs of those living with PD:

Bayer AG

30,744 просмотров • 2 лет назад

Penn Medicine’s Carl June, MD, has won the 2024 Breakthrough Prize in Life Sciences for his work in CAR T cell therapy. T cell therapy marked a transformative moment in medicine & opened new possibilities for personalized therapies for patients worldwide. Congrats, Dr. June!
0:30

Penn Medicine’s Carl June, MD, has won the 2024 Breakthrough Prize in Life Sciences for his work in CAR T cell therapy. T cell therapy marked a transformative moment in medicine & opened new possibilities for personalized therapies for patients worldwide. Congrats, Dr. June!

Penn Medicine

48,230 просмотров • 2 лет назад

Looking for a new year's resolution with a difference for 2025? Joining the stem cell register means you will be on our lifesaving list and ready to help, if you are found to be a match for someone in need of a stem cell transplant. 💚
0:34

Looking for a new year's resolution with a difference for 2025? Joining the stem cell register means you will be on our lifesaving list and ready to help, if you are found to be a match for someone in need of a stem cell transplant. 💚

Anthony Nolan

33,718 просмотров • 1 год назад

With the goal of advancing cell therapies for patients like JC Cox, MD Anderson has launched the Institute for Cell Therapy Discovery & Innovation. Read more: Katy Rezvani, M.D., Ph.D #EndCancer
1:05

With the goal of advancing cell therapies for patients like JC Cox, MD Anderson has launched the Institute for Cell Therapy Discovery & Innovation. Read more: Katy Rezvani, M.D., Ph.D #EndCancer

UT MD Anderson

29,976 просмотров • 1 год назад

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:
1:29

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough T1D

42,350 просмотров • 1 год назад

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻
1:24

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻

Liz Churchill

976,914 просмотров • 1 месяц назад

Mercedes Moné announces that she’s in Mexico undergoing stem cell therapy and she wants to return to the ring soon better than ever! CEO FC WE’RE GOING BACK TO BACK ON WOMEN’S WRESTLER OF THE YEAR! STEM CELL CEDES IS GUNNA BE DIFFERENT 😭🔥
0:59

Mercedes Moné announces that she’s in Mexico undergoing stem cell therapy and she wants to return to the ring soon better than ever! CEO FC WE’RE GOING BACK TO BACK ON WOMEN’S WRESTLER OF THE YEAR! STEM CELL CEDES IS GUNNA BE DIFFERENT 😭🔥

Self Made AO 💫

97,618 просмотров • 3 месяцев назад

Mercedes Moné getting stem cell therapy and enjoying her time in Mexico. 💰
0:39

Mercedes Moné getting stem cell therapy and enjoying her time in Mexico. 💰

Drainmaker

12,636 просмотров • 3 месяцев назад

🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back. Now the FDA has approved this therapy for Phase 1 in the US. This is XS-411. And it might be the most important stem cell story you haven't heard. 🧵 Thread 👇
0:20

🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back. Now the FDA has approved this therapy for Phase 1 in the US. This is XS-411. And it might be the most important stem cell story you haven't heard. 🧵 Thread 👇

Harshi Peiris, Ph.D.

53,392 просмотров • 2 месяцев назад

We’re delighted to hear that exa-cel has been approved by NICE to treat sickle cell disorder! This innovative gene therapy is the first of its kind, offering a potential cure to people without a stem cell donor.
1:00

We’re delighted to hear that exa-cel has been approved by NICE to treat sickle cell disorder! This innovative gene therapy is the first of its kind, offering a potential cure to people without a stem cell donor.

Anthony Nolan

20,037 просмотров • 1 год назад

How advanced Ancient India was in medicine and stem cell therapy 1000 years ago ??? #AmazingIndia
1:36

How advanced Ancient India was in medicine and stem cell therapy 1000 years ago ??? #AmazingIndia

SriSathya

130,612 просмотров • 1 год назад

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.
1:50

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.

𝘊𝘰𝘳𝘳𝘪𝘯𝘦

12,921 просмотров • 1 месяц назад

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:
4:40

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type 1 diabetes. $SANA Full video:

BiotechTV

19,210 просмотров • 4 месяцев назад

Watch this on-demand Masterclass to hear practical, case-based insights into CAR T-cell therapy for patients with R/R DLBCL or R/R FL. Our experts discuss bridging therapy, other essential aspects of pre- and post-infusion management, identifying appropriate patients, and more.
0:22

Watch this on-demand Masterclass to hear practical, case-based insights into CAR T-cell therapy for patients with R/R DLBCL or R/R FL. Our experts discuss bridging therapy, other essential aspects of pre- and post-infusion management, identifying appropriate patients, and more.

Springer Health+ Education

27,318,337 просмотров • 6 месяцев назад

Parkinson’s. There isn’t one journey. There isn’t one ‘day in the life’. This #WorldParkinsonsDay, we’re shining a light on the daily lives of people with Parkinson’s and their loved ones. The good. The bad. The funny. The sad. The ons. The offs. And everything in between. 💙
2:19

Parkinson’s. There isn’t one journey. There isn’t one ‘day in the life’. This #WorldParkinsonsDay, we’re shining a light on the daily lives of people with Parkinson’s and their loved ones. The good. The bad. The funny. The sad. The ons. The offs. And everything in between. 💙

Parkinson's UK

437,895 просмотров • 2 лет назад

NEW TREATMENT APPROVED FOR SICKLE CELL! We are delighted that NICE has today approved the groundbreaking gene therapy, Exa-cel, or Casgevy, for use through the NHS in people living with sickle cell disorder. Our CEO John James OBE comments here.
1:33

NEW TREATMENT APPROVED FOR SICKLE CELL! We are delighted that NICE has today approved the groundbreaking gene therapy, Exa-cel, or Casgevy, for use through the NHS in people living with sickle cell disorder. Our CEO John James OBE comments here.

Sickle Cell Society

21,856 просмотров • 1 год назад

Johnny Lubin was one of the youngest patients in the clinical trial supporting today’s approval of the first CRISPR treatment in the US, one of two therapies approved today for sickle cell. He told us how the therapy has changed his life:
2:20

Johnny Lubin was one of the youngest patients in the clinical trial supporting today’s approval of the first CRISPR treatment in the US, one of two therapies approved today for sickle cell. He told us how the therapy has changed his life:

Meg Tirrell

26,914 просмотров • 2 лет назад

This is the result of getting unalived human collagen, salmon sperm, and stem cell therapy injected in your face
1:20

Sensitive content

This is the result of getting unalived human collagen, salmon sperm, and stem cell therapy injected in your face

TaraBull

4,262,129 просмотров • 3 месяцев назад

Team Route 66 Bikers Set Off from Chicago to Phoenix to Raise Parkinson’s Awareness CHICAGO — A group of cyclists known as “Team Route 66” began a cross-country journey on Monday morning, riding from Chicago to Phoenix to raise awareness and funds for Parkinson’s disease. The “Pedal for Parkinson’s” ride departed Navy Pier at around 10:30 a.m. The team includes about a dozen riders living with Parkinson’s and aims to reach Phoenix by May 24 for the World Parkinson Conference. The event brings together researchers, clinicians, nutritionists, patients, and caregivers focused on advancing understanding and treatment of the disease. VIA: ABC 7 Chicago
0:24

Team Route 66 Bikers Set Off from Chicago to Phoenix to Raise Parkinson’s Awareness CHICAGO — A group of cyclists known as “Team Route 66” began a cross-country journey on Monday morning, riding from Chicago to Phoenix to raise awareness and funds for Parkinson’s disease. The “Pedal for Parkinson’s” ride departed Navy Pier at around 10:30 a.m. The team includes about a dozen riders living with Parkinson’s and aims to reach Phoenix by May 24 for the World Parkinson Conference. The event brings together researchers, clinicians, nutritionists, patients, and caregivers focused on advancing understanding and treatment of the disease. VIA: ABC 7 Chicago

Breaking911

18,676 просмотров • 1 месяц назад

Tamil Nadu govt inaugrates Hemato- Oncology and Bone Marrow transplant center in Egmore. Its 8 floors with 132 beds with a dedicated stem cell transplant unit. Equipped with ICU, isolation rooms and stem cell plasmapheresis. Blood cancers such as leukemias and Lymphomas will be treated here for free 🖤♥️
0:43

Tamil Nadu govt inaugrates Hemato- Oncology and Bone Marrow transplant center in Egmore. Its 8 floors with 132 beds with a dedicated stem cell transplant unit. Equipped with ICU, isolation rooms and stem cell plasmapheresis. Blood cancers such as leukemias and Lymphomas will be treated here for free 🖤♥️

Kavi

39,040 просмотров • 3 месяцев назад